Ocular Therapeutix
OCUL
OCUL
68 hedge funds and large institutions have $99.9M invested in Ocular Therapeutix in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
13% more capital invested
Capital invested by funds: $88.6M → $99.9M (+$11.3M)
0.89% more ownership
Funds ownership: 52.11% → 53% (+0.89%)
0% more funds holding
Funds holding: 68 → 68 (0)
Holders
68
Holding in Top 10
4
Calls
$1.23M
Puts
$647K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$2.6M | |
| 3 | +$1.91M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.03M |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$2.84M | |
| 3 | -$1.14M | |
| 4 |
Jennison Associates
New York
|
-$1M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$688K |